Pfizer's Consumer Healthcare sales rise by 4%

31 January 2017 - Deborah Wilkes

Archived

Pfizer said worldwide sales at its Consumer Healthcare business had increased by 4% on an operational basis to USD950 million in the fourth quarter of 2016. The rise for the full year was 5% to USD3.41 billion.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: